Sean McClain is the founder and CEO, and Gregory Hannum is the VP of AI Research at Absci, a biotech company that's using deep learning to expedite drug discovery and development. Lukas, Sean, and Greg talk about why Absci started investing so heavily in ML research (it all comes back to the data), what it'll take to build the GPT-3 of DNA, and where the future of pharma is headed. Sean and Greg also share some of the challenges of building cross-functional teams and combining two highly specialized fields like biology and ML. The complete show notes (transcript and links) can be found here: http://wandb.me/gd-sean-and-greg --- Connect with Sean and Greg: 

Sean & Greg — Biology and ML for Drug Discovery

Join Lukas Biewald on Gradient Dissent, an AI-focused podcast brought to you by Weights & Biases. Dive into fascinating conversations with industry giants from NVIDIA, Meta, Google, Lyft, OpenAI, and more. Explore the cutting-edge of AI and learn the intricacies of bringing models into production.

Technology

Tech News

Podcasting

Gadgets

Software How-To

In this episode of Gradient Dissent, Isomorphic Labs Chief AI Officer Max Jaderberg, and Chief Technology Officer Sergei Yakneen join our host Lukas Biewald to discuss the advancements in biotech and drug discovery being unlocked with machine learning. With backgrounds in advanced AI research at DeepMind, Max and Sergei offer their unique insights into the challenges and successes of applying AI in a complex field like biotechnology. They share their journey at Isomorphic Labs, a company dedicated to revolutionizing drug discovery with AI. In this episode, they discuss the transformative impact of deep learning on the drug development process and Isomorphic Labs' strategy to innovate from molecular design to clinical trials. You’ll come away with valuable insights into the challenges of applying AI in biotech, the role of AI in streamlining the drug discovery pipeline, and peer into the  future of AI-driven solutions in healthcare. Connect with Sergei Yakneen & Max Jaderberg: https://www.linkedin.com/in/maxjaderberg/  https://www.linkedin.com/in/yakneensergei/  https://twitter.com/SergeiIakhnin  https://twitter.com/maxjaderberg  Follow Weights & Biases: https://twitter.com/weights_biases  https://www.linkedin.com/company/wandb  


Accelerating drug discovery with AI: Insights from Isomorphic Labs

Redefining AI Hardware for Enterprise with SambaNova’s Rodrigo Liang

Navigating the Vector Database Landscape with Pinecone's Edo Liberty

 In this episode of Gradient Dissent, we explore the revolutionary impact of AI across industries with Clara Shih, CEO of Salesforce AI and Founder of Hearsay Systems.  Dive into Salesforce AI's cutting-edge approach to customer service through AI, the importance of a trust-first strategy, and the future of AI policies and education. Learn how Salesforce empowers businesses and shapes the future with AI innovations like Prompt Builder and Copilot Studio. Whether you're an AI enthusiast, a business leader, or someone curious about the future of technology, this discussion offers valuable insights into navigating the rapidly evolving world of AI. Subscribe to Weights & Biases YouTube →  https://bit.ly/45BCkYz Get our podcasts on these platforms: Apple Podcasts: http://wandb.me/apple-podcasts Spotify: http://wandb.me/spotify Google: http://wandb.me/gd_google Connect with Clara: https://www.linkedin.com/in/clarashih/ https://x.com/clarashih?s=20   Follow Weights & Biases: https://twitter.com/weights_biases  https://www.linkedin.com/company/wandb 

Transforming Data into Business Solutions with Salesforce AI CEO, Clara Shih

In the newest episode of Gradient Dissent, we explore the intersecting worlds of AI and Healthcare with John Halamka, President of the Mayo Clinic Platform. Journey with us down John Halamka's remarkable path from his early tech startup days to leading innovations as the President of the Mayo Clinic Platform, one of the world's most esteemed healthcare institutions. This deep dive into AI's role in modern medicine covers the technology's evolution, its potential to redefine patient care, and the visionary work of Mayo Clinic Platform in harnessing AI responsibly. Explore the misconceptions surrounding AI in healthcare and discover the ethical and regulatory frameworks guiding its application. Glimpse into the future with Halamka's visionary perspective on AI's potential to democratize and revolutionize healthcare across the globe. Join us for an enlightening discussion on the challenges, triumphs, and the horizon of AI in healthcare through the lens of John Halamka's pioneering experiences. 

Sean & Greg — Biology and ML for Drug Discovery

Download our free app to listen on your phone